BioNTech ready to boost mRNA vaccine for 2021 !

ketchim · 12-22-2020, 12:57 PM · 1 person reading this discussion

#2
Efficacy results of more than 90 per cent and approvals around the world have set off a race

between countries for additional supplies of the precious shots,

with the U.S. seeking to exercise an option for a hundred million.

Most of the doses anticipated for next year -- enough to immunize 650 million people --

have already been spoken for.

#3
More than 2 million people in six countries have already gotten their first shot

#4
BioNTech is seeking more of the raw materials it needs for its mRNA vaccine

more clean rooms and more cooperation partners

The company also needs additional space to formulate the shots

put them into containers and prepare them for shipping ~

#5
New Strain Tests

The shot will probably be effective against the new SARS-CoV-2 strain that has emerged in the U.K

Lab tests of the vaccine’s performance have already been done

against 20 mutant versions of SARS-CoV-2


; the same tests will now be done against the new U.K. version,

and should take about two weeks

#6
“This virus has multiple mutations, but as far as we know, 99% of the spike protein is not mutated,”

[size=4]“Let’s do the experiment and get the result.


hat’s always the best answer, but I would emphasize just to stay calm.”

#7
Coronavirus spreads to Antarctica !

The Virus has reached all 7 Continents !

Coronavirus has reached the Antarctic continent, which had so far been free of Covid-19.

The Chilean army has reported 36 cases at its Bernardo O'Higgins research station on the Antarctic Peninsula.

The 36, 26 of whom are military personnel and 10 maintenance workers, have been evacuated to Chile.

#8
[img ]https://ichef.bbci.co.uk/news/976/cpsprodpb/37D2/production/_116209241_gettyimages-1204285729.jpg[/img]

#9
Moderna Vaccine will start distributing ~

LTC homes are their target ~

#10
https://www.pfizer.com/news/press-releas...onal-doses

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX)

today announced a second agreement with the U.S. government to supply an additional 100 million doses

of the companies’ COVID-19 Vaccine from production facilities in the U.S.

This agreement brings the total number of doses to be delivered to the U.S. to 200 million.

The companies expect to deliver the full 200 million doses to Operation Warp Speed by July 31, 2021.

Consistent with the original agreement announced in July 2020,

the U.S. government will pay $1.95 billion for the additional 100 million doses.

From The Archives

Older threads about similar topics


Users browsing this thread: 1 Guest(s)